Prof. Vivek Padgaonkar is a distinguished healthcare policy expert and industry advisor who serves as a non-executive independent director at Entod Pharmaceuticals, a research-driven pharmaceutical organization specializing in ophthalmology, ENT, and dermatology medicines with a global footprint across more than 60 countries. In this role, he contributes strategic oversight and policy insight to support the company’s innovation agenda and long-term growth in advanced pharmaceutical research and development.

Prof. Padgaonkar brings extensive experience from his work across healthcare policy, industry advocacy, and strategic advisory roles. Earlier in his career, he served as Director – Projects & Policy at the Organization of Pharmaceutical Producers of India, where he played an important role in policy dialogue between the pharmaceutical industry and government stakeholders. Through this position, he collaborated with several ministries and regulatory bodies, contributing to the shaping of pharmaceutical policies and frameworks that support innovation, access to medicines, and responsible industry growth in India.

Recognized for his deep understanding of healthcare systems and regulatory environments, Prof. Padgaonkar has been actively involved with think-tanks, industry bodies, and advisory platforms that focus on healthcare reform, pharmaceutical innovation, and public health policy. His work has emphasized strengthening the interface between industry, research institutions, and government in order to build a more robust and globally competitive pharmaceutical ecosystem.

In addition to his role at Entod Pharmaceuticals, he also serves as an independent director on the boards of several organizations, including Martin & Harris Labs, Bervin Investment & Leasing Limited, and Juvenor Healthcare. These positions reflect his broad expertise in governance, healthcare strategy, and policy engagement across the pharmaceutical sector.

Through his academic insight, policy experience, and governance leadership, Prof. Vivek Padgaonkar continues to contribute to the advancement of pharmaceutical innovation and responsible healthcare development, supporting initiatives that strengthen research, technology adoption, and regulatory collaboration within India’s evolving life sciences ecosystem.